169744-02-9

Basic information

• Product Name: Carbamic acid, [2-[2-(2-aminoethoxy)ethoxy]ethyl]-, phenylmethyl ester
• CAS NO: 169744-02-9
• Molecular Formula: C14H22N2O4
• Molecular Weight: 282.34
• Mol File: 169744-02-9.mol
• Article Data: 12

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [2-[2-(2-aminoethoxy)ethoxy]ethyl]-, phenylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [2-[2-(2-aminoethoxy)ethoxy]ethyl]-, phenylmethyl ester(169744-02-9)
• EPA Substance Registry System: Carbamic acid, [2-[2-(2-aminoethoxy)ethoxy]ethyl]-, phenylmethyl ester(169744-02-9)

Safety Data

• Hazardous Substances Data: 169744-02-9(Hazardous Substances Data)

Upstream product

• 86520-52-7 2-[2-(2-azidoethoxy)ethoxy]ethanol 
• 205535-92-8 2-[2-{2-(N-benzyloxycarbonyl)aminoethoxy}ethoxy]ethanol 
• 6338-55-2 2-(2-(2-aminoethoxy)ethoxy)ethan-1-ol 
• 13139-17-8 N-(Benzyloxycarbonyloxy)succinimide 
• 929-59-9 3,6-dioxa-1,8-diaminooctane 
• 501-53-1 benzyl chloroformate 

Downstream Products

• 474903-38-3 2-(2-{2-[2-(benzyloxycarbonylamino)ethoxy]ethoxy}ethylamino)ethyl 2-O-(2-acetamido-3,4,6-tri-O-benzyl-2-deoxy-β-D-glucopyranosyl)-3-O-carbamoyl-α-D-galactopyranosiduronamide 
• 885313-16-6 {2-[2-(2-benzyloxycarbonylamino-ethoxy)-ethoxy]-ethylamino}-acetic acid tert-butyl ester 
• 1007222-11-8 C₂₁H₃₃N₃O₈ 
• 904673-02-5 C₁₈H₂₆N₂O₇ 
• 1590422-27-7 N-[8'-(benzyloxycarbonylamino)-3',6'-dioxaaminooctyl]-3α,7α,12α-trihydroxy-5β-cholan-24-amide 
• 1590422-26-6 (8'-((2-boronobenzyl)amino)-3′,6′-dioxaaminooctyl)-3α,7α,12α-trihydroxy-5β-cholan-24-amide 

Relevant articles and documents

Microwave-Assisted Synthesis and Physicochemical Characterization of Tetrafuranylporphyrin-Grafted Reduced-Graphene Oxide

This work describes the design of a modified porphyrin that bears four furan rings linked by 1,2-bis-(2-aminoethoxy)ethane spacers. This unit is a well-suited scaffold for a Diels-Alder reaction with commercial reduced-graphene oxide, which is also described in this paper. A new hybrid material is obtained, thanks to efficient grafting under microwave irradiation, and fully characterized in terms of structure (UV, TGA, Raman) and morphology (HR-TEM and AFM). Potential applications in photo- and sonodynamic therapy are envisaged.

CONJUGATES COMPRISING SELF-IMMOLATIVE GROUPS AND METHODS RELATED THERETO

In some aspects, the invention relates to an antibody-drug conjugate, comprising an antibody; a linker; and an active agent. The antibody-drug conjugate may comprise a self- immolative group. The linker may comprise an O-substituted oxime, e.g., wherein the oxygen atom of the oxime is substituted with a group that covalently links the oxime to the active agent; and the carbon atom of the oxime is substituted with a group that covalently links the oxime to the antibody.

Polylysine dendrimer contrast agent

The present invention relates generally to branched macromolecules and their use as imaging or contrast agents. In particular, the invention relates to dendrimers, derived from lysine or lysine analogs, bearing a plurality of functional moieties and their application to imaging techniques in which a disease state may be imaged with a targeted contrast agent.